GlassScriptPhysician profile
Richard T Perry
NPI 1467414052
$2,208.37
in general payments reported to CMS, 2019-2025
15 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $221 · 2021: $99.59 · 2022: $858 · 2023: $49.49 · 2024: $153 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,268.47 | 2019-2025 | Persona |
| Ferring Pharmaceuticals INC. | $256.99 | 2019-2021 | |
| Bioventus LLC | $132.65 | 2020-2025 | Bonescalpel & Sonicone (O.R.) |
| Pacira Therapeutics, INC. | $119.67 | 2019-2020 | |
| Smith+Nephew, INC. | $104.87 | 2019-2023 | Pico 7 |
| Fidia Pharma USA INC. | $103.75 | 2019-2023 | Hyalgan |
| Sanofi-Aventis U.S. LLC | $46.81 | 2019 | |
| Convatec INC. | $39.91 | 2019-2020 | |
| Polynovo North America LLC | $32.83 | 2025 | Novosorb Btm |
| E.R. Squibb & Sons, L.L.C. | $21.91 | 2022 | |
| Argentum Medical | $20.09 | 2023 | |
| Solventum Corporation | $19.51 | 2024 | Prevena |
| Orthofix Medical, INC. | $14.60 | 2021 | |
| Depuy Synthes Sales INC. | $14.14 | 2024 | Monovisc |
| Pinnacle, INC | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.